Jeffrey Farrow
Director of Finance/CFO presso TARSUS PHARMACEUTICALS, INC.
Patrimonio netto: 41 201 $ in data 31/03/2024
Profilo
Jeffrey S.
Farrow is currently an Independent Non-Executive Director at Clover Biopharmaceuticals Ltd.
since 2021 and the Chief Financial & Strategy Officer at Tarsus Pharmaceuticals, Inc. since 2023.
Previously, he served as the Chief Financial Officer, Director & Senior VP at Hyperion Therapeutics, Inc. from 2014 to 2015, the Chief Accounting Officer & Vice President-Finance at Renovis, Inc. from 2004 to 2008, the Chief Financial Officer at ZS Pharma, Inc. from 2015 to 2016, and a Senior Manager at KPMG LLP from 1996 to 2004.
He also worked as the Vice President-Finance at Evotec SE from 2008 to 2010 and as an Associate at Cooley Godward LLP.
Additionally, he served as the Chief Financial & Accounting Officer at Global Blood Therapeutics, Inc. from 2016 to 2022.
Mr. Farrow obtained his undergraduate degree from California State University-Fullerton in 1993.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 07/03/2024 | 700 ( 0.00% ) | 25 445 $ | 31/03/2024 | |
| 02/04/2024 | 300 750 ( 0.02% ) | 15 756 $ | 31/03/2024 |
Posizioni attive di Jeffrey Farrow
| Società | Posizione | Inizio |
|---|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Director/Board Member | 19/04/2021 |
| TARSUS PHARMACEUTICALS, INC. | Director of Finance/CFO | 24/04/2023 |
Precedenti posizioni note di Jeffrey Farrow
| Società | Posizione | Fine |
|---|---|---|
| GLOBAL BLOOD THERAPEUTICS, INC. | Director of Finance/CFO | 01/12/2022 |
| ZS PHARMA INC | Director of Finance/CFO | 01/03/2016 |
| EVOTEC SE | Director of Finance/CFO | 01/01/2010 |
Renovis, Inc.
 Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | Comptroller/Controller/Auditor | 01/05/2008 |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/2004 |
Formazione di Jeffrey Farrow
| California State University-Fullerton | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| EVOTEC SE | Health Technology |
| TARSUS PHARMACEUTICALS, INC. | Health Technology |
| CLOVER BIOPHARMACEUTICALS, LTD. | Health Technology |
| Aziende private | 6 |
|---|---|
Renovis, Inc.
Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | Health Technology |
Hyperion Therapeutics, Inc.
 Hyperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Hyperion Therapeutics, Inc. developed and commercialized pharmaceutical products. The company was founded by Mark Blumling and Christopher Eugene Rivera on November 1, 2006 and headquartered in Brisbane, CA. | Health Technology |
ZS Pharma, Inc.
 ZS Pharma, Inc. Pharmaceuticals: MajorHealth Technology ZS Pharma, Inc. engages in the development of development and commercialization of non-absorbed drugs to treat renal, cardiovascular, liver and metabolic diseases. It develops treatment of hyperkalemia. It also focuses on clinical development, novel technology, and clinical trials. The company was founded by Alvaro F. Guillem and Donald Jeffrey Keyser on February 5, 2008 and is headquartered in San Mateo, CA. | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Commercial Services |
Cooley Godward LLP
 Cooley Godward LLP Miscellaneous Commercial ServicesCommercial Services Cooley Goodword LLP is the law firm specializes in providing services to both new and established information technology and life sciences companies. Cooley also provides counsel in areas of business law that include trade regulation, employment and labor, investment banking issues, securities litigation, IPOs, mergers and acquisitions, patent enforcement and venture capital funding. It is located in Palo Alto, CA. | Commercial Services |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Jeffrey Farrow
